SlideShare a Scribd company logo
1 of 23
VITAMIN A DEFFICIENCY
Prepared by
George deogratias MD5 student.
Archbishop James university college the constitute of
st.augustine university of Tanzania.
(biziriko1991@gmail.com)
+255656592079
03/25/181
Cont…
 Vitamin A is a broad term for a number of
similar compounds , First recognized fat
soluble vitamin
 Two forms :
a) Preformed vitamin A: retinoids ( from
animals)
b) Provitamin A: carotenoids
(predominantly beta carotene from
plants)
03/25/18
Dr george
2
CONT…
Preformed vitamin A: Retinoids
 Active or usable form
 Four categories of retinoids:
a) retinol (b) retinal
c) retinoic acid (d) retinyl esters
All retinoids are absorbed as retinol.
Sources: animal products like liver, fish , fish
oils ,
milk , eggs etc.
 Liver is richest source
03/25/18
Dr george
3
Cont…
 ProvitaminA: Carotenoids
 Precursor of vitamin A
 Predominantly beta carotene
 Body has to convert it into active vitamin
A after
 consumption
 Sources: plant products like carrot , green
leafy
 vegetables , papaya , mango , bringal.
03/25/18
george
4
Functions of Vitamin A
(Retinol)
 Vitamin A is essential to the normal
structure and function of the skin and
mucous membranes
 It is also required for cell differentiation
and therefore for normal growth and
development
 For normal vision
 For the immune system.
03/25/185
Cont…
 Important in wound healing, bone
formation (e.g., teeth), healthy skin and
growth and lactation. 
 Further, it may also be a factor in
preventing cancers. 
 It has been shown to have antiviral
properties.
03/25/186
Metabolism
 Normally, the liver stores 80 to 90% of
the body's vitamin A.
 To use vitamin A, the body releases it
into the circulation bound to
prealbumin (retinol-binding protein)
 β-Carotene and other provitamin
carotenoids, contained in green leafy
and yellow vegetables and deep- or
bright-colored fruits, are converted to
vitamin A.
03/25/187
VITAMIN A DEFICIENCY-
CAUSES;
 Inadequate intake-
 Fat malabsorption- sprue, cystic fibrosis,
pancreatic insufficiency, duodenal
bypass, chronic diarrhea, bile duct
obstruction, giardiasis
 liver disorders -cirrhosis
03/25/188
XEROPHTHALMIA
 General term applied to all the ocular
manifestations of impaired vitamin A
metabolism, from night blindness through
complete corneal destruction
 Xeros – dry
 ophthalmia – eye
 literally means “ dry eye “
 conventionally xerophthalmia has become
synonymous
 with vitamin A deficiency
03/25/18
Dr george
9
WHO Classification of
xerophthalmia
 XN (Night blindness)
 X1A ( Conjunctival xerosis)
 X1B ( Bitot’s spots)
 X2 ( Corneal xerosis)
 X3A ( Corneal ulceration/Keratomalacia affecting
less than one third corneal surface)
 X3B ( Corneal ulceration/Keratomalacia affecting
more than one third corneal surface)
 XS ( Corneal scars)
 XF ( Xerophthalmic fundus)
 Biochemical criterion: Plasma vitamin A < 0.35
μmol/L
03/25/1810
Cont…
 Is a major cause of preventable blindness in
children and especially in developing countries
 It is an inflammation of the cornea that is
associated with nutritional deficiency
 Risk factors-
 general malnutrition, diarrhea, measles, HIV/AIDS,
failure to thrive, lack of food diversity
 Although xerophthalmia is most prevalent with
children, it can also occur in adults with severe
malnutrition or in other health problems in which
lack of vitamin A in their diets is a factor.
03/25/1811
Cont…
 Night blindness, is an early symptom
 Superficial foamy patches composed of
epithelial debris and secretions on the
exposed bulbar conjunctiva (Bitot's spots
 It involves drying (xerosis) and thickening
of the conjunctivae and corneas.
 cornea erosions- keratomalacia
03/25/1812
Other systems
 There is keratinization of Skin, drying,
scaling, and follicular thickening of the
skin
 Mucous membranes disorders in the
respiratory, GI, and urinary tracts can
occur- infections
 Immunity is generally impaired
03/25/1813
Bitot spots
The Bitot’s spot is a
raised, silvery white, foamy, triangular patch
of
keratinised epithelium, situated on the
bulbar conjunctiva in the inter-palpebral
area
Note; usually bilateral and temporal, and
less frequently nasal.
03/25/1814
Corneal Xerosis
 The earliest change in the cornea is
punctate keratopathy .
 which begins in the lower nasal quadrant,
followed by haziness and/or granular
pebbly dryness
 Involved cornea lacks lustre.
Dr george deogratias
03/25/18
15
XFC (Xerophthalmic fundus)
03/25/18
Dr george
16
 It is characterized by
 typical seed-like, raised, whitish lesions
scattered uniformly over the part of the
fundus at the level of optic disc
Treatment-Xerophthalmia
 Apply an antibiotic -to prevent
secondary bacterial infection.
Ointment, e.g. tetracycline or
chloramphenicol
 Protect the eye with an eye shield in
order to prevent trauma.
 Vitamin A must be administered orally
immediately upon diagnosis-
03/25/1817
Treatment
 50,000 IU for infants < 6 mo, 100,000 IU
for infants 6 to 12 mo,
 200,000 IU for children > 12 mo and
adults should be given for 2 days; with
a third dose at least 2 wk later.
 For pregnant or lactating women,
prophylactic or therapeutic doses
should not exceed 10,000 IU /day to
avoid possible damage to the fetus or
infant
03/25/1819
Cont…
 A. MEDICAL
 Antibiotcs, Mydiatrics
 Pad specially in X3A, X3B
 Avoid Exposure: Antibiotic Ointment
 Methyl Cellulose Drops
03/25/18
Dr george
20
Cont…
B. SURGERY
1. Conjunctivoplasty
2. Keratoplasty
a. Prophylactic
b. Optical
REHABILITATION
03/25/18
Dr george
21
Prevention
 Improve diet- dark green leafy vegetables,
deep- or bright-colored fruits (eg, papayas,
oranges), carrots, and yellow vegetables (eg,
squash, pumpkin).
 Vitamin A–fortified milk and cereals, liver, egg
yolks, and fish liver oils are helpful.
 Carotenoids are absorbed better when
consumed with some dietary fat.
 Prophylactic supplements of vitamin A
palmitate in oil 60,000 RAE (200,000 IU) po every
6 mo- for all children between 1 - 5 years of
age; infants < 6 mo-1year can be given a one-
time dose of 15,000 RAE (50,000-100,000 IU),
03/25/1822
Vitamin A Toxicity
 Accidental ingestion by children-more
than 300,000IU
 or chronic
 It usually occurs by taking more that 50,000 IU per
day for more than 3 months.
 It can lead to dry skin, mouth sores, vomiting, and
poor appetite.
 Eventually, it can cause increased pressure within the
brain, headaches, and problems thinking clearly.  It
may also lead to an enlarged liver or to liver failure.
 There is evidence that high levels of retinol may
increase the risk of birth defects.
03/25/1823
,
Ahsanteni sana
03/25/18
Dr george deogratias
24

More Related Content

Similar to Vitamin a deficiency

Similar to Vitamin a deficiency (20)

Vitamin deficiency disorders 1916 priyanka
Vitamin deficiency disorders 1916 priyankaVitamin deficiency disorders 1916 priyanka
Vitamin deficiency disorders 1916 priyanka
 
Vitamin A deficiency
Vitamin A deficiencyVitamin A deficiency
Vitamin A deficiency
 
vitamins : hyper and hypovitaminosis.pptx
vitamins : hyper and hypovitaminosis.pptxvitamins : hyper and hypovitaminosis.pptx
vitamins : hyper and hypovitaminosis.pptx
 
Vitamin A MUHAMMAD MUSTANSAR
Vitamin  A   MUHAMMAD MUSTANSAR Vitamin  A   MUHAMMAD MUSTANSAR
Vitamin A MUHAMMAD MUSTANSAR
 
vitamins.pptx
vitamins.pptxvitamins.pptx
vitamins.pptx
 
Vitamins _ POSITIVE HOMEOPATHY
Vitamins _ POSITIVE HOMEOPATHYVitamins _ POSITIVE HOMEOPATHY
Vitamins _ POSITIVE HOMEOPATHY
 
13 14. vitamins and minerals
13 14. vitamins and minerals13 14. vitamins and minerals
13 14. vitamins and minerals
 
Micronutrients
MicronutrientsMicronutrients
Micronutrients
 
Vitamin a
Vitamin aVitamin a
Vitamin a
 
Fat Soluble Vitamins
Fat Soluble VitaminsFat Soluble Vitamins
Fat Soluble Vitamins
 
Vitamins (fat and water soluble)
Vitamins (fat and water soluble)Vitamins (fat and water soluble)
Vitamins (fat and water soluble)
 
Vitamin and mineral deficiency.pdf
Vitamin  and mineral deficiency.pdfVitamin  and mineral deficiency.pdf
Vitamin and mineral deficiency.pdf
 
Micronutrients in health and diseases
Micronutrients in health and diseasesMicronutrients in health and diseases
Micronutrients in health and diseases
 
Vitamin Deficiency.pptx
Vitamin Deficiency.pptxVitamin Deficiency.pptx
Vitamin Deficiency.pptx
 
Vitamins.pdf
Vitamins.pdfVitamins.pdf
Vitamins.pdf
 
Fat soluble vitamins
Fat soluble vitaminsFat soluble vitamins
Fat soluble vitamins
 
Topic vitamin a
Topic  vitamin aTopic  vitamin a
Topic vitamin a
 
Vitamins.pptx
Vitamins.pptxVitamins.pptx
Vitamins.pptx
 
Fat -soluble vitamins.pptx
Fat -soluble  vitamins.pptxFat -soluble  vitamins.pptx
Fat -soluble vitamins.pptx
 
Fat soluble vitamins
Fat soluble vitaminsFat soluble vitamins
Fat soluble vitamins
 

Recently uploaded

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 

Recently uploaded (20)

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 

Vitamin a deficiency

  • 1. VITAMIN A DEFFICIENCY Prepared by George deogratias MD5 student. Archbishop James university college the constitute of st.augustine university of Tanzania. (biziriko1991@gmail.com) +255656592079 03/25/181
  • 2. Cont…  Vitamin A is a broad term for a number of similar compounds , First recognized fat soluble vitamin  Two forms : a) Preformed vitamin A: retinoids ( from animals) b) Provitamin A: carotenoids (predominantly beta carotene from plants) 03/25/18 Dr george 2
  • 3. CONT… Preformed vitamin A: Retinoids  Active or usable form  Four categories of retinoids: a) retinol (b) retinal c) retinoic acid (d) retinyl esters All retinoids are absorbed as retinol. Sources: animal products like liver, fish , fish oils , milk , eggs etc.  Liver is richest source 03/25/18 Dr george 3
  • 4. Cont…  ProvitaminA: Carotenoids  Precursor of vitamin A  Predominantly beta carotene  Body has to convert it into active vitamin A after  consumption  Sources: plant products like carrot , green leafy  vegetables , papaya , mango , bringal. 03/25/18 george 4
  • 5. Functions of Vitamin A (Retinol)  Vitamin A is essential to the normal structure and function of the skin and mucous membranes  It is also required for cell differentiation and therefore for normal growth and development  For normal vision  For the immune system. 03/25/185
  • 6. Cont…  Important in wound healing, bone formation (e.g., teeth), healthy skin and growth and lactation.   Further, it may also be a factor in preventing cancers.   It has been shown to have antiviral properties. 03/25/186
  • 7. Metabolism  Normally, the liver stores 80 to 90% of the body's vitamin A.  To use vitamin A, the body releases it into the circulation bound to prealbumin (retinol-binding protein)  β-Carotene and other provitamin carotenoids, contained in green leafy and yellow vegetables and deep- or bright-colored fruits, are converted to vitamin A. 03/25/187
  • 8. VITAMIN A DEFICIENCY- CAUSES;  Inadequate intake-  Fat malabsorption- sprue, cystic fibrosis, pancreatic insufficiency, duodenal bypass, chronic diarrhea, bile duct obstruction, giardiasis  liver disorders -cirrhosis 03/25/188
  • 9. XEROPHTHALMIA  General term applied to all the ocular manifestations of impaired vitamin A metabolism, from night blindness through complete corneal destruction  Xeros – dry  ophthalmia – eye  literally means “ dry eye “  conventionally xerophthalmia has become synonymous  with vitamin A deficiency 03/25/18 Dr george 9
  • 10. WHO Classification of xerophthalmia  XN (Night blindness)  X1A ( Conjunctival xerosis)  X1B ( Bitot’s spots)  X2 ( Corneal xerosis)  X3A ( Corneal ulceration/Keratomalacia affecting less than one third corneal surface)  X3B ( Corneal ulceration/Keratomalacia affecting more than one third corneal surface)  XS ( Corneal scars)  XF ( Xerophthalmic fundus)  Biochemical criterion: Plasma vitamin A < 0.35 μmol/L 03/25/1810
  • 11. Cont…  Is a major cause of preventable blindness in children and especially in developing countries  It is an inflammation of the cornea that is associated with nutritional deficiency  Risk factors-  general malnutrition, diarrhea, measles, HIV/AIDS, failure to thrive, lack of food diversity  Although xerophthalmia is most prevalent with children, it can also occur in adults with severe malnutrition or in other health problems in which lack of vitamin A in their diets is a factor. 03/25/1811
  • 12. Cont…  Night blindness, is an early symptom  Superficial foamy patches composed of epithelial debris and secretions on the exposed bulbar conjunctiva (Bitot's spots  It involves drying (xerosis) and thickening of the conjunctivae and corneas.  cornea erosions- keratomalacia 03/25/1812
  • 13. Other systems  There is keratinization of Skin, drying, scaling, and follicular thickening of the skin  Mucous membranes disorders in the respiratory, GI, and urinary tracts can occur- infections  Immunity is generally impaired 03/25/1813
  • 14. Bitot spots The Bitot’s spot is a raised, silvery white, foamy, triangular patch of keratinised epithelium, situated on the bulbar conjunctiva in the inter-palpebral area Note; usually bilateral and temporal, and less frequently nasal. 03/25/1814
  • 15. Corneal Xerosis  The earliest change in the cornea is punctate keratopathy .  which begins in the lower nasal quadrant, followed by haziness and/or granular pebbly dryness  Involved cornea lacks lustre. Dr george deogratias 03/25/18 15
  • 16. XFC (Xerophthalmic fundus) 03/25/18 Dr george 16  It is characterized by  typical seed-like, raised, whitish lesions scattered uniformly over the part of the fundus at the level of optic disc
  • 17. Treatment-Xerophthalmia  Apply an antibiotic -to prevent secondary bacterial infection. Ointment, e.g. tetracycline or chloramphenicol  Protect the eye with an eye shield in order to prevent trauma.  Vitamin A must be administered orally immediately upon diagnosis- 03/25/1817
  • 18. Treatment  50,000 IU for infants < 6 mo, 100,000 IU for infants 6 to 12 mo,  200,000 IU for children > 12 mo and adults should be given for 2 days; with a third dose at least 2 wk later.  For pregnant or lactating women, prophylactic or therapeutic doses should not exceed 10,000 IU /day to avoid possible damage to the fetus or infant 03/25/1819
  • 19. Cont…  A. MEDICAL  Antibiotcs, Mydiatrics  Pad specially in X3A, X3B  Avoid Exposure: Antibiotic Ointment  Methyl Cellulose Drops 03/25/18 Dr george 20
  • 20. Cont… B. SURGERY 1. Conjunctivoplasty 2. Keratoplasty a. Prophylactic b. Optical REHABILITATION 03/25/18 Dr george 21
  • 21. Prevention  Improve diet- dark green leafy vegetables, deep- or bright-colored fruits (eg, papayas, oranges), carrots, and yellow vegetables (eg, squash, pumpkin).  Vitamin A–fortified milk and cereals, liver, egg yolks, and fish liver oils are helpful.  Carotenoids are absorbed better when consumed with some dietary fat.  Prophylactic supplements of vitamin A palmitate in oil 60,000 RAE (200,000 IU) po every 6 mo- for all children between 1 - 5 years of age; infants < 6 mo-1year can be given a one- time dose of 15,000 RAE (50,000-100,000 IU), 03/25/1822
  • 22. Vitamin A Toxicity  Accidental ingestion by children-more than 300,000IU  or chronic  It usually occurs by taking more that 50,000 IU per day for more than 3 months.  It can lead to dry skin, mouth sores, vomiting, and poor appetite.  Eventually, it can cause increased pressure within the brain, headaches, and problems thinking clearly.  It may also lead to an enlarged liver or to liver failure.  There is evidence that high levels of retinol may increase the risk of birth defects. 03/25/1823